par Lipton, Allan;Steger, Guenther;Figueroa, Jazmin;Alvarado, Cristina;Solal-Celigny, Philippe;Body, Jean-Jacques ;De Boer, Richard;Berardi, Rossana;Gascon, Pere;Tonkin, Katia;Coleman, Robert;Paterson, Alexander H. G.;Peterson, Mark C.;Fan, Michelle;Kinsey, Amy C.;Jun, Susie
Référence Journal of clinical oncology, 25, 28, page (4431-4437)
Publication Publié, 2007-10
Référence Journal of clinical oncology, 25, 28, page (4431-4437)
Publication Publié, 2007-10
Article révisé par les pairs
Titre: |
|
Auteur: | Lipton, Allan; Steger, Guenther; Figueroa, Jazmin; Alvarado, Cristina; Solal-Celigny, Philippe; Body, Jean-Jacques; De Boer, Richard; Berardi, Rossana; Gascon, Pere; Tonkin, Katia; Coleman, Robert; Paterson, Alexander H. G.; Peterson, Mark C.; Fan, Michelle; Kinsey, Amy C.; Jun, Susie |
Informations sur la publication: | Journal of clinical oncology, 25, 28, page (4431-4437) |
Statut de publication: | Publié, 2007-10 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Antibodies, Monoclonal -- administration & dosage -- adverse effects -- therapeutic use | |
Biological Markers -- metabolism | |
Bone Density Conservation Agents -- administration & dosage -- adverse effects -- therapeutic use | |
Bone Neoplasms -- drug therapy -- secondary | |
Bone Resorption -- prevention & control | |
Breast Neoplasms -- pathology | |
Collagen Type I -- drug effects -- metabolism | |
Computer Simulation | |
Double-Blind Method | |
Drug Administration Schedule | |
Drug Toxicity | |
Female | |
Humans | |
Infusions, Intravenous | |
Injections, Subcutaneous | |
Kaplan-Meier Estimate | |
Middle Aged | |
Peptides -- drug effects -- metabolism | |
RANK Ligand | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2007.11.8604 | |
info:pii/JCO.2007.11.8604 | |
info:pmid/17785705 |